An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer.
Biochem Biophys Res Commun
; 718: 149931, 2024 Jul 23.
Article
in En
| MEDLINE
| ID: mdl-38723415
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Herpesvirus 1, Human
/
Oncolytic Viruses
/
Oncolytic Virotherapy
/
Nicotinamide Phosphoribosyltransferase
/
Tumor Microenvironment
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos